Intravascular catheter-related sepsis - Novel methods of prevention

Intensive Care Medicine, Supplement

Volumn 26, Issue 1, 2000, Pages

  Elliott, T ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; CHLORHEXIDINE GLUCONATE; HYDROMER; MINOCYCLINE; POVIDONE IODINE; RIFAMPICIN; SULFADIAZINE SILVER; TEICOPLANIN; TETRACYCLINE; UNCLASSIFIED DRUG;

BANDAGES AND DRESSINGS; CATHETER INFECTION; CATHETERIZATION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HUMAN; INTRAVASCULAR CATHETER; MULTICENTER STUDY; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-INFECTIVE AGENTS, LOCAL; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; HUMANS; MICROBIAL SENSITIVITY TESTS; RISK FACTORS; SEPSIS;

EID: 0034026081     PISSN: 09351701     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Maki DG (1994) Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention and management. In: Bisno AI, Waldvogel FA (eds) Infections associated with indwelling medical devices, 2nd ed. ASM Press, Washington, DC, pp 155-205
2. Elliott TSJ (1997) Catheter-associated infections: new developments in prevention. In: Buchard H (ed) Current topics in intensive care, Vol 4. WB Saunders, London, pp 182-205
3. Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 271: 1598-1601
4. Moss HA, Elliott TSJ (1997) The cost of infections related to central venous catheters designed for long-term use. Br J Med Econ 11: 1-7
5. Elliott TSJ (1993) Line-associated bacteraemias. Commun Dis Rep 3: R23-R24. Public Health Laboratory Services, Colindale, London
6. Elliott TSJ, Lambert PA (1999) Antibacterial resistance in the intensive care unit, mechanisms and management. Br Med Bull 55: 259-276
7. Elliott TSJ, Moss HA, Tebbs SE, et al (1997) A novel approach to investigate the source of microbial contamination of central venous catheters. Eur J Clin Microbiol 16: 210-213
8. Elliott TSJ (1988) Intravascular-device infections. J Med Microbiol 27: 161-167
9. Elliott TSJ (1999) Role of antimicrobial central venous catheters for the prevention of associated infections. J Antimicrob Chemother 43: 441-446
10. Elliott TSJ (1999) Can antimicrobial central venous catheters prevent associated infection? Br J Haematol (in press)
11. Milder F (1999) Device-related nosocomial infection. Med Device Technol 10: 34-39
12. Elliott TSJ, Tebbs SE (1998) Prevention of central venous catheter-related infection. J Hosp Infect 40: 193-201
13. Elliott TSJ, Faroqui MH (1992) Infections and intravascular devices. Br J Hosp Med 48: 496-503
14. Elliott TSJ, Faroqui MH, Armstrong RF, Hanson GC (1994) Guidelines of good practice in central venous catheterisation. Hospital Infection Society and the Research Unit of the Royal College of Physicians. J Hosp Infect 28: 163-176
15. Maki DG, Ringer M, Alvarado CJ (1991) Prospective randomized trial of povidone iodine, alcohol and chlorhexidine for the prevention of infection associated with central venous and arterial catheters. Lancet 338: 339-343
16. Hoffman KK, Wever DJ, Samsa GP, Rutala WA (1992) Transparent polyurethane film as an intravenous catheter dressing: a meta analysis of the infection risks. JAMA 267: 2072-2076
17. Reynolds MG, Tebbs SE, Elliott TSJ (1997) Do dressings with increased permeability reduce the incidence of central venous catheter related sepsis? Intensive Crit Care Nurs 13: 26-29
18. Baranowski L (1989) Central venous access devices; current technologies, uses and management strategies. J Intraven Nursing 126: 167-194
19. Tebbs SE, Ghose A, Elliott TSJ (1996) Microbial contamination of intravenous and arterial catheters. Intensive Care Med 22: 272-273
20. Tebbs SE, Trend V, Elliott TSJ (1995) The potential reduction of microbial contamination of central venous catheters. J Infect 30: 107-113
21. Brown JD, Moss HA, Elliott TSJ (1997) The potential for catheter microbial contamination from a needleless connector. J Hosp Infect 36: 181-189
22. Elliott TSJ, Faroqui MH, Tebbs SE, Armstrong RF, Hanson GC (1995) An audit programme for central venous catheter-associated infections. J Hosp Infect 30: 181-191
23. Tebbs SE, Elliott TSJ (1994) Modification of central venous catheter polymers to prevent in vitro microbial colonization. Eur J Clin Microbiol Infect Dis 13: 111-117
24. Romano G, Berti M, Goldstein BP, Borghi A (1993) Efficacy of a central venous catheter (Hydrocath®) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse. Zentralbl Bakteriol Mikrobiol Hygiene 279: 426-433
25. Jansen B, Jansen S, Peters G, Pulverer G (1992) In-vitro efficacy of a central venous catheter ('Hydrocath') loaded with teicoplanin to prevent bacterial colonization. J Hosp Infect 22: 93-107
26. Bach A, Darby D, Böttiger B, Böhrer H, Motsch J, Martin E (1996) Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients. Intensive Care Med 22: 1066-1069
27. Raad I, Darouiche R, Dupuis J, AbiSaid D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C, and the Texas Medical Center Catheter Study Group (1997) Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med 127: 267-274
28. Darouiche R, Raad I, Heard S, Rand K, Khardori N, Harris R, Wenker O, Mayhall G (1997) A prospective, randomized, multicenter clinical trial comparing central venous catheters impregnated with minocycline and rifampin vs. chlorhexidine gluconate and silver sulfadiazine. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, Abstract LB-22
29. Darouriche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G (1999) A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 340:1-8
30. Jansen B, Kristinsson KG, Jansen S, Peters G, Pulverer G (1992) In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization. J Antimicrob Chemother 30: 135-139
31. Modak SM, Sampath L (1992) Development and evaluation of a new polyurethane central venous antiseptic catheter: reducing central venous catheter infections. Infect Med: 23-29
32. Clemence MA, Jernigan JA, Titus MA, Duani DK, Farr BM (1993) A study of an antiseptic impregnated central venous catheter for prevention of bloodstream infections. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Chemotherapy, New Orleans, LA, Abstract 1624. American Society for Microbiology, Washington, DC, p 416
33. Maki DG, Stolz SM, Wheeler S, Mermel LA (1997) Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter - a randomized, controlled trial. Ann Intern Med 127: 257-266
34. Logghe C, Van Ossel C, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ (1997) Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 37: 145-156
35. Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E (1996) No difference in catheter sepsis between standard and antiseptic central venous catheters. Arch Surg 131: 986-989
36. Criesi DL, Albrecht RM, Volkers PA, Scholten DJ (1996) Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 62: 641-646
37. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD (1999) Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. JAMA 281: 261-267
38. Jansen B, Rinck M, Wolbring P, Strohmeier A, Jahns T (1994) In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter. J Biomater App 9: 55-70
39. Elliott TSJ, Tebbs SE (1993) Intravascular catheters impregnated with benzalkonium chloride. J Antimicrob Chemother 32: 905-906
40. Moss HA, Tebbs SE, Faroqui MH, Herbst T, Isaac JL, Brown J, Elliott TSJ (1999) Benzalkonium chloride for the prevention of intravascular catheter-related sepsis (in preparation)
41. Elliott TSJ, Holford J, Sisson P, Byrne P (1990) A novel method to prevent catheter-associated infections. J Med Microbiol 33: 2
42. Liu W-K, Tebbs SE, Byrne PO, Elliott TSJ (1993) The effects of electric current on bacteria colonising intravenous catheters. J Infect 27: 261-269
43. Liu W-K, Brown MWR, Elliott TSJ (1997) Mechanisms of the bacterial activity of low amperage electric current (DC). J Antimicrob Chemother 39: 687-695
44. Raad I, Hachem R, Zermeno A (1996) Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. J Infect Dis 173: 495-498
45. Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE (1994) Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Ag Chemother 38: 2803-2809